Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors

Cited by (1,002)

Items 201–300 of 1,002

1. Risk factors for early-onset pancreatic ductal adenocarcinoma: A systematic literature review
   Sreenivasa Rao Chandana, Laura M. Woods, Fiona Maxwell, Ruth Gandolfo, Tanios Bekaii‐Saab · 2023 · European Journal of Cancer
2. Preoperative CTC-Detection by CellSearch® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
   Harald Hugenschmidt, Knut Jørgen Labori, Elin Borgen, Cathrine Brunborg, Cecilie Bendigtsen Schirmer, Lars Thomas Seeberg, Bjørn Naume, Gro Wiedswang · 2021 · Cancers
3. Stage IV Pancreatic Cancer Patient Treated With FOLFIRINOX Combined With Oral Methioninase: A Highly-Rare Case With Long-term Stable Disease
   Yutaro Kubota, Qinghong Han, CHIHIRO HOZUMI, NORIYUKI MASAKI, Jun Yamamoto, YUSUKE AOKI, Takuya Tsunoda, Robert M. Hoffman · 2022 · Anticancer Research
4. Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype
   Sven‐Thorsten Liffers, Laura Godfrey, Lisa Frohn, Lena Häberle, Aslihan Yavas, Rita Vesce, Wolfgang Goering, Friederike V. Opitz, Nikolas Hendrik Stoecklein, Wolfram Trudo Knoefel et al. · 2022 · Gut
5. Quercetin improves pancreatic cancer chemo‐sensitivity by regulating oxidative‐inflammatory networks
   Yaoyuan Hu, Rui Li, Junyi Jin, Yihui Wang, Rui Ma · 2022 · Journal of Food Biochemistry
6. A blood-based metabolomic signature predictive of risk for pancreatic cancer
   Ehsan Irajizad, Ana Kenney, Tiffany M. Tang, Jody Vykoukal, Ranran Wu, Eunice N. Murage, Jennifer B. Dennison, Marta Sans, James Patrick Long, Maureen Loftus et al. · 2023 · Cell Reports Medicine
7. Pancreatic Cancer (PDAC): Introduction of Evidence-Based Complementary Measures into Integrative Clinical Management
   Valerie Jentzsch, James Davis, Mustafa B.A. Djamgoz · 2020 · Cancers
8. Impact of FAPI-PET/CT on Target Volume Definition in Radiation Therapy of Locally Recurrent Pancreatic Cancer
   Jakob Liermann, Mustafa Syed, Edgar Ben‐Josef, Kai Schubert, Ingmar Schlampp, Simon David Sprengel, Jonas Ristau, Fabian Weykamp, Manuel Röhrich, Stefan Alexander Koerber et al. · 2021 · Cancers
9. A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
   Yousra Mohamed Abd-El-Halim, Abdessamad El Kaoutari, Françoise Silvy, Marion Rubis, Martin Bigonnet, Julie Roques, Jerome F. Cros, Rémy Nicolle, Juan Iovanna, Nelson Dusetti et al. · 2021 · EBioMedicine
10. Current and Future Therapies for Pancreatic Ductal Adenocarcinoma
    Áine Sally, Ryan McGowan, Karen Finn, Brian Michael Moran · 2022 · Cancers
11. Fatty infiltration of the pancreas: a systematic concept analysis
    Mueataz A. Mahyoub, Mohamed Elhoumed, Abdulfatah Hassan Maqul, Maged Almezgagi, Mustafa A. Abbas, Yang Jiao, Jinhai Wang, Mohammed Alnaggar, Ping Zhao, Shuixiang He · 2023 · Frontiers in Medicine
12. Somatostatin and Somatostatin Receptors in Tumour Biology
    Ujendra Kumar · 2023 · International Journal of Molecular Sciences
13. Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer
    Jing Wang, Lei Zhao, Kun Shang, Fang Liu, Juanjuan Che, Huihui Li, Bangwei Cao · 2020 · Molecular Medicine
14. Alcohol Use and Gastrointestinal Cancer Risk
    Hans Scherübl · 2020 · Visceral Medicine
15. The construction and analysis of a ferroptosis-related gene prognostic signature for pancreatic cancer
    Peicheng Jiang, Feng Yang, Caifeng Zou, Tianyuan Bao, Mengmeng Wu, Dongqin Yang, Shurui Bu · 2021 · Aging
16. Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
    Greta Brezgyte, Vinay M. Shah, Daria Jach, Tatjana Crnogorac‐Jurcevic · 2021 · Cancers
17. Pancreatic adenocarcinoma: A review of recent paradigms and advances in epidemiology, clinical diagnosis and management
    Nikhil Gupta, Raghav Yelamanchi · 2021 · World Journal of Gastroenterology
18. Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer.
    Bittoni, Alessandro, Pecci, Federica, Mentrasti, Giulia, Crocetti, Sonia, Lupi, Alessio, Lanese, Andrea, Pellei, Chiara, Ciotti, Chiara, Cantini, Luca, Giampieri, Riccardo et al. · 2021 · Annals of Translational Medicine
19. Pancreatic Cancer Detection using Machine and Deep Learning Techniques
    Anish Gupta, Apeksha Koul, Yogesh Kumar · 2022 · International Conference on Innovative Practices in Technology and Management (ICIPTM)
20. Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan
    Tomoki Sakakida, Takeshi Ishikawa, Toshifumi Doi, Ryuichi Morita, Seita Kataoka, Hayato Miyake, Kanji Yamaguchi, Michihisa Moriguchi, Yoshio Sogame, Hiroaki Yasuda et al. · 2023 · Journal of Gastroenterology
21. An Update on Protein Kinases as Therapeutic Targets—Part I: Protein Kinase C Activation and Its Role in Cancer and Cardiovascular Diseases
    Shmuel Silnitsky, Samuel J. S. Rubin, Mulate Zerihun, Nir Qvit · 2023 · International Journal of Molecular Sciences
22. Cross-Talk Between Cancer and Its Cellular Environment—A Role in Cancer Progression
    Eliza Turlej, Aleksandra Domaradzka, Justyna Radzka, Dominika Drulis‐Fajdasz, Julita Kulbacka, Agnieszka Gizak · 2025 · Cells
23. New Era of Endoscopic Ultrasound-Guided Tissue Acquisition: Next-Generation Sequencing by Endoscopic Ultrasound-Guided Sampling for Pancreatic Cancer
    Hiroshi Imaoka, Mitsuhito Sasaki, Yusuke Hashimoto, Kazuo Watanabe, Masafumi Ikeda · 2019 · Journal of Clinical Medicine
24. The Role of Autophagy in Pancreatic Cancer: From Bench to the Dark Bedside
    Kıvanç Görgülü, Kalliope Nina Diakopoulos, Ezgi Kaya-Aksoy, Katrin J. Ciecielski, Jiaoyu Ai, Marina Lesina, Hana Algül · 2020 · Cells
25. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma
    Fangshi Xu, Zhengliang Zhang, Yidi Zhao, Yang Zhou, Honghong Pei, Ling Bai · 2021 · Gene
26. Advanced Nanoengineering Approach for Target‐Specific, Spatiotemporal, and Ratiometric Delivery of Gemcitabine–Cisplatin Combination for Improved Therapeutic Outcome in Pancreatic Cancer
    Mubin Tarannum, Md Akram Hossain, Bryce M. Holmes, Shan Yan, Pinku Mukherjee, Juan Luis Vivero-Escoto · 2021 · Small
27. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma
    Xing Chen, Zhenglin Wang, Yating Zhu, Chao Zhang, Miao Liu, Xianyu Hu, Wei Chen, Yinan Du · 2020 · International Journal of Medical Sciences
28. Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer
    Laura Cecilia Laurella, Nadia Talin Mirakian, María Noé Garcia, Daniel Grasso, Valeria Patricia Sülsen, Daniela Laura Papademetrio · 2022 · Molecules
29. Transformer guided progressive fusion network for 3D pancreas and pancreatic mass segmentation
    Taiping Qu, Xiuli Li, Xiheng Wang, Wenyi Deng, Li Mao, Ming Xuan He, Xiao Li, Yun Wang, Zaiyi Liu, Long Jiang Zhang et al. · 2023 · Medical Image Analysis
30. Cancer-on-chip: a 3D model for the study of the tumor microenvironment
    Elisa Cauli, Michela Anna Polidoro, Simona Marzorati, Claudio Bernardi, Marco Rasponi, Ana Lleò · 2023 · Journal of Biological Engineering
31. Mg2+ Transporters in Digestive Cancers
    Julie Auwercx, Pierre Rybarczyk, Philippe Kischel, Isabelle Duthille, Denis Chatelain, Henri Sevestre, Isabelle VAN SEUNINGEN, Halima Ouadid‐Ahidouch, Nicolas Jonckheere, Mathieu Gautier · 2021 · Nutrients
32. N6-methyladenosine-mediated SH3BP5-AS1 upregulation promotes GEM chemoresistance in pancreatic cancer by activating the Wnt signaling pathway
    Chengjie Lin, Yan Wang, Yihong Dong, Shihui Lai, Liang Wang, Shangeng Weng, Xiang Zhang · 2022 · Biology Direct
33. NetrinG1(+) cancer-associated fibroblasts generate unique extracellular vesicles that support the survival of pancreatic cancer cells under nutritional stress
    Raghavan, Kristopher S., Francescone, Ralph, Franco-Barraza, Janusz, Gardiner, Jaye C., Vendramini-Costa, Débora B., Luong, Tiffany, Pourmandi, Narges, Andren, Anthony, Kurimchak, Alison, Ogier, Charline et al. · 2022 · Cancer Research Communications
34. Therapeutic Strategies to Overcome Fibrotic Barriers to Nanomedicine in the Pancreatic Tumor Microenvironment
    Hiroyoshi Y. Tanaka, Takuya Nakazawa, Atsushi Enomoto, Atsushi Masamune, Mitsunobu R. Kano · 2023 · Cancers
35. Upregulation of ZIP14 and Altered Zinc Homeostasis in Muscles in Pancreatic Cancer Cachexia
    Ahmad Rushdi Shakri, Timothy James Zhong, Wanchao Ma, Courtney Coker, Sean Kim, Stephanie Calluori, Hanna Scholze, Matthias J. Szabolcs, Thomas C. Caffrey, Paul M. Grandgenett et al. · 2019 · Cancers
36. Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development
    Shannon R. Nelson, Chenxi Zhang, Sandra Roche, Fiona O’Neill, Niall Swan, Yonglun Luo, Annemarie Larkin, John Paul Crown, Naomi Walsh · 2020 · Scientific Reports
37. siRNA-Loaded Hydroxyapatite Nanoparticles for KRAS Gene Silencing in Anti-Pancreatic Cancer Therapy
    Dandan Luo, Xiaochun Xu, M. Zubair Iqbal, Qingwei David Zhao, Ruibo Zhao, Jabeen Farheen, Quan Zhang, Peiliang Zhang, Xiangdong Kong · 2021 · Pharmaceutics
38. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation
    Chao Wu, Zhihong Huang, Ziqi Meng, Xiaotian Fan, Shan Lu, Yingying Tan, Leiming You, Jiaqi Huang, Antony Stalin, Pei-Zhi Ye et al. · 2021 · Chinese Medicine
39. Oncologic Benefits of Neoadjuvant Treatment versus Upfront Surgery in Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
    Hye‐Sol Jung, Hyeong Seok Kim, Jae Seung Kang, Yoon Hyung Kang, Hee Ju Sohn, Yoonhyeong Byun, Youngmin Han, Won‐Gun Yun, Young Jae Cho, Mirang Lee et al. · 2022 · Cancers
40. Survival After Minimally Invasive vs Open Surgery for Pancreatic Adenocarcinoma
    Halit Topal, Raymond Aerts, Annouschka Laenen, Andre M. F. Collignon, Joris Jaekers, Joachim Geers, Baki Topal · 2022 · JAMA Network Open
41. Fatty acid oxidation is critical for the tumorigenic potential and chemoresistance of pancreatic cancer stem cells
    Marta Mascaraque, Sarah Courtois, Alba Royo-García, David Barneda, Andrei M. Stoian, Isabel Villaoslada, Pilar Espiau-Romera, Ansooya A. Bokil, Andrés Cano-Galiano, Petra Jagušt et al. · 2024 · Journal of Translational Medicine
42. Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications
    Medhavi Gupta, Renuka V. Iyer, Christos K Fountzilas · 2019 · Cancers
43. Heterotypic 3D pancreatic cancer model with tunable proportion of fibrotic elements
    Hiroyoshi Y. Tanaka, Tsuyoshi Kurihara, Takuya Nakazawa, Michiya Matsusaki, Atsushi Masamune, Mitsunobu R. Kano · 2020 · Biomaterials
44. The Role of Dysfunctional Adipose Tissue in Pancreatic Cancer: A Molecular Perspective
    Davide Brocco, Rosalba Florio, Laura De Lellis, Serena Veschi, Antonino Grassadonia, Nicola Tinari, Alessandro Cama · 2020 · Cancers
45. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go
    Elizabeth D. Thompson, Nicholas Jason Roberts, Laura DeLong Wood, James R. Eshleman, Michael Goggins, Scott E. Kern, Alison P. Klein, Ralph H. Hruban · 2020 · Modern Pathology
46. Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic adenocarcinoma
    Kunwar Somesh Vikramdeo, Shashi Anand, Mohammad Aslam Khan, Moh'd M. Khushman, Martin J. Heslin, Seema Singh, Ajay Pratap Singh, Santanu Dasgupta · 2022 · Scientific Reports
47. An epidemiological review of pancreatic cancer with special reference to India
    Rajshree H. Gaidhani, Ganesh Balasubramaniam · 2020 · Indian Journal of Medical Sciences
48. Early-onset pancreatic cancer: a review of molecular mechanisms, management, and survival
    Mark Bilinyi Ulanja, Alastair E. Moody, Bryce David Beutler, Daniel Antwi‐Amoabeng, Ganiyu A. Rahman, Olatunji Boladale Alese · 2022 · Oncotarget
49. Mechanically stressed cancer microenvironment: Role in pancreatic cancer progression
    Matthew Kyle Hadden, Anubhav Mittal, Jaswinder Singh Samra, Hala Zreiqat, Sumit Sahni, Yogambha Ramaswamy · 2020 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
50. Extracellular Vesicles as Potential Biomarkers for Early Detection and Diagnosis of Pancreatic Cancer
    Nelson S. Yee, Sheng Zhang, Hong-Zhang He, Siyang Zheng · 2020 · Biomedicines
51. Longitudinal analysis of cell-free mutated KRAS and CA 19–9 predicts survival following curative resection of pancreatic cancer
    Saskia Hussung, Dilara Akhoundova, Julian Hipp, Marie Follo, Rhena F. U. Klar, Ulrike Philipp, Florian Scherer, Nikolas C. C. von Bubnoff, Justus Duyster, Melanie Boerries et al. · 2021 · BMC Cancer
52. pH-Sensitive Nanoparticles Composed Solely of Membrane-Disruptive Macromolecules for Treating Pancreatic Cancer
    Feng Fan, Lijun Jin, Lihua Yang · 2021 · ACS Applied Materials & Interfaces
53. Metastatic pancreatic cancer: Mechanisms and detection (Review)
    Xiangling Chen, Fangfang Liu, Qingping Xue, Xiechuan Weng, Fan Xu · 2021 · Oncology Reports
54. Autophagy: A Key Player in Pancreatic Cancer Progression and a Potential Drug Target
    Josef Gillson, Yomna S. Abd El-Aziz, Lionel Yi Wen Leck, Patric J. Jansson, Nick Pavlakis, Jaswinder Singh Samra, Anubhav Mittal, Sumit Sahni · 2022 · Cancers
55. Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
    Annah Grace Morgan, Michelle Griffin, Lionel E. Kameni, Derrick C. Wan, Michael Thornton Longaker, Jeffrey Allen Norton · 2023 · Biology
56. The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study
    Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Kaur Chela, Ebubekir S. Daglilar · 2024 · Cancers
57. ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer
    Nikhil Gupta, Jung Eun Park, Wilford Tse, Jee Keem Low, Oi Lian Kon, Neil E. McCarthy, Siu Kwan Sze · 2019 · Oncotarget
58. Epidemiology of HPB malignancy in the elderly
    Marinos Pericleous, Shahid Ahmed Khan · 2020 · European Journal of Surgical Oncology
59. Eukaryotic translation initiation factor 5A in the pathogenesis of cancers (Review)
    Liang Ning, Lei Wang, Honglai Zhang, Xuelong Jiao, Dong Chen · 2020 · Oncology Letters
60. circSFMBT1 promotes pancreatic cancer growth and metastasis via targeting miR-330-5p/PAK1 axis
    Shu Xu, San-Lin Lei, Kuijie Liu, Shengen Yi, Zhulin Yang, Hong-Liang Yao · 2020 · Cancer Gene Therapy
61. SMAD4 loss limits the vulnerability of pancreatic cancer cells to complex I inhibition via promotion of mitophagy
    Zuzana Ezrova, Zuzana Nahácka, Jan Štursa, Lukáš Werner, Erik Vlčák, Petra Králová Viziová, Michael V. Berridge, Radislav Sedláček, Renata Zobalová, Jakub Rohlena et al. · 2021 · Oncogene
62. Targeting hedgehog signaling in pancreatic ductal adenocarcinoma
    Delphine Quatannens, Yannick Verhoeven, Peter A. van Dam, Filip Lardon, Hans Prenen, Geert Roeyen, Marc Peeters, Evelien Smits, Jonas R.M. Van Audenaerde · 2022 · Pharmacology & Therapeutics
63. Deep evidential fusion network for medical image classification
    Shaoxun Xu, Yufei Chen, Chao Ma, Xiaodong Yue · 2022 · International Journal of Approximate Reasoning
64. Liver metastases in pancreatic ductal adenocarcinoma: a predictive model based on CT texture analysis
    Riccardo De Robertis, Luca Geraci, Luisa Tomaiuolo, Luca Bortoli, Alessandro Beleù, Giuseppe Malleo, Mirko D’Onofrio · 2022 · La radiologia medica
65. Molecular targets and therapeutic potential of baicalein: a review
    Kavita Munjal, Yash Goel, Vinod Kumar Gauttam, Hitesh Chopra, Madhav Singla, Smriti, Saurabh Gupta, Rohit Sharma · 2024 · Drug Target Insights
66. MEX3A knockdown inhibits the development of pancreatic ductal adenocarcinoma
    Xing Wang, Yuqiang Shan, Qingquan Tan, Chunlu Tan, Hao Zhang, Jin-Heng Liu, Nengwen Ke, Yong‐Hua Chen, Xu-Bao Liu · 2020 · Cancer Cell International
67. Topically applicated curcumin/gelatin-blended nanofibrous mat inhibits pancreatic adenocarcinoma by increasing ROS production and endoplasmic reticulum stress mediated apoptosis
    Tao Cheng, Zhiheng Zhang, Hua Shen, Ziying Jian, Junsheng Li, Yujun Chen, Yi Shen, Xinyi Dai · 2020 · Journal of Nanobiotechnology
68. Reliability and Quality of YouTube Contents Pertaining to Pancreatic Cancer
    Güner Çakmak, Barış Mantoğlu · 2021 · Cureus
69. Evaluation of Adjuvant Chemotherapy Survival Outcomes Among Patients With Surgically Resected Pancreatic Carcinoma With Node-Negative Disease After Neoadjuvant Therapy
    Abdulrahman Y. Hammad, Jacob C. Hodges, Samer S. AlMasri, Alessandro Paniccia, Kenneth K.W. Lee, Nathan Bahary, Aatur Dilip Singhi, Susannah G. Ellsworth, Mohammed Aldakkak, Douglas B. Evans et al. · 2022 · JAMA Surgery
70. Artificial Intelligence in Pancreatic Image Analysis: A Review
    Weixuan Liu, Bairui Zhang, Tao Liu, Juntao Jiang, Yong Liu · 2024 · Sensors
71. Targeting lipid metabolism: novel insights and therapeutic advances in pancreatic cancer treatment
    Yanyan Zhang, Zhichao Yang, Yuchen Liu, Jinjin Pei, Ruo-Jie Li, Yanhui Yang · 2025 · Lipids in Health and Disease
72. The Impact on Survival and Morbidity of Portal–Mesenteric Resection During Pancreaticoduodenectomy for Pancreatic Head Adenocarcinoma: A Systematic Review and Meta-Analysis of Comparative Studies
    Alessandro Fancellu, Niccolò Petrucciani, Alberto Porcu, Giulia Deiana, Valeria Sanna, Chiara Ninniri, Teresa Perra, Valentina Celoria, Giuseppe R. Nigri · 2020 · Cancers
73. Deubiquitinase USP18 promotes the progression of pancreatic cancer via enhancing the Notch1-c-Myc axis
    Long Feng, Kai Wang, Ping Tang, Suyun Chen, Tiande Liu, Jun Lei, Rongfa Yuan, Zhigang Hu, Wen Li, Xin Yu · 2020 · Aging
74. Simultaneous targeting of primary tumor, draining lymph node, and distant metastases through high endothelial venule-targeted delivery
    Liwei Jiang, Sungwook Jung, Jing Zhao, Vivek Kasinath, Takaharu Ichimura, John Joseph, Paolo Fiorina, Andrew Scott Liss, Khalid Shah, Nasim Annabi et al. · 2020 · Nano Today
75. Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy
    Man Kyu Shim, Jinhee Na, In Kyung Cho, Eun Hyang Jang, Jooho Park, Sangmin Lee, Jong-Ho Kim · 2021 · Journal of Controlled Release
76. Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
    Kaushal, Jyoti, Bhatia, Rakesh, Kanchan, Ranjana, Raut, Pratima, Mallapragada, Surya, Ly, Quan, Batra, Surinder, Rachagani, Satyanarayana · 2021 · Cancers
77. Mebendazole disrupts stromal desmoplasia and tumorigenesis in two models of pancreatic cancer
    Tara Williamson, Michelle Carvalho de Abreu, Dimitri G. Trembath, Cory F. Brayton, Byunghak Kang, Thais Biude Mendes, Paulo Pimentel de Assumpção, Janete Maria Cerutti, Gregory Joseph Riggins · 2021 · Oncotarget
78. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells
    Lara Magni, Rayhana Bouazzi, Hugo Heredero Olmedilla, Patricia S. S. Petersen, Marco Tozzi, Ivana Novak · 2021 · Cells
79. Procedure‐specific morbidity of pancreatoduodenectomy: a systematic review of incidence and risk factors
    Thomas Brendon Russell, Somaiah Aroori · 2022 · ANZ Journal of Surgery
80. Deep Learning Applications in Pancreatic Cancer
    Hardik Patel, Theodoros P. Zanos, Daniel Brock Hewitt · 2024 · Cancers
81. Propensity score-matching analysis comparing laparoscopic and open pancreaticoduodenectomy in elderly patients
    Heeji Shin, Ki Byung Song, Young Il Kim, Young Joo Lee, Dae Wook Hwang, Jae Hoon Lee, Sang Hyun Shin, Jaewoo Kwon, Shadi A. Alshammary, Guisuk Park et al. · 2019 · Scientific Reports
82. Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data Analysis
    Guangwei Tian, Guang Li, Peipei Liu, Zihui Wang, Nan Li · 2020 · DNA and Cell Biology
83. Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 signaling
    Chenjing Wang, Xin Li, Ping Shi, Haiyan Ding, Yanping Liu, Ting Li, Pingping Lin, Yunshan Wang, Guo-qing Zhang, Yu Cao · 2020 · Cell Death and Disease
84. Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens
    Zev A. Wainberg, Kynan Feeney, Myung Ah Lee, Andrés Jesús Muñoz Martín, Antonio Cubillo Gracián, Sara Lonardi, Baek‐Yeol Ryoo, Annie Hung, Yong Lin, Johanna C. Bendell et al. · 2020 · BMC Cancer
85. Aptamers: a novel targeted theranostic platform for pancreatic ductal adenocarcinoma
    Qiongshan Li, Sebastian H. Maier, P. Li, Julian Peterhansl, Claus Belka, Julia V. Mayerle, Ujjwal Mukund Mahajan · 2020 · Radiation Oncology
86. Metabolic Characterization of Plasma and Cyst Fluid from Cystic Precursors to Pancreatic Cancer Patients Reveal Metabolic Signatures of Bacterial Infection
    Ann Morgell, Julie A. Reisz, Zeeshan Ateeb, Haleh Davanian, Susanne Erika Reinsbach, Asif Halimi, Rogier Aäron Gaiser, Roberto Valente, Urban Arnelo, Marco Del Chiaro et al. · 2021 · Journal of Proteome Research
87. Model-Driven Deep Learning Method for Pancreatic Cancer Segmentation Based on Spiral-Transformation
    Chen, Xiahan, Chen, Zihao, Li, Jun, Zhang, Yu-Dong, Lin, Xiaozhu, Qian, Xiaohua · 2022 · IEEE Transactions on Medical Imaging
88. Hemostatic Biomarkers and Venous Thromboembolism Are Associated With Mortality and Response to Chemotherapy in Patients With Pancreatic Cancer
    Florian Moik, Gerald W. Prager, J. Thaler, Florian Posch, Sarah Wiedemann, Theresa Schramm, Cornelia Englisch, Nigel Mackman, Ingrid Pabinger, Cihan Ay · 2021 · Arteriosclerosis Thrombosis and Vascular Biology
89. Macropinocytic dextran facilitates KRAS-targeted delivery while reducing drug-induced tumor immunity depletion in pancreatic cancer
    Yuan Fang, Mengnan Sun, Zhengsheng Liu, Huiqin Liu, Weijian Kong, Rui Wang, Feng Qian · 2022 · Theranostics
90. Plasma Exosome-Derived microRNAs as Potential Diagnostic and Prognostic Biomarkers in Brazilian Pancreatic Cancer Patients
    Anelis Maria Marin, Sibelle Botogosque Mattar, Rafaela F. Amatuzzi, Roger J. Chammas, Miyuki Uno, Dalila Lucíola Zanette, Mateus Nóbrega Aoki · 2022 · Biomolecules
91. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
    Xiong Tian, Jing Zheng, Wanlan Mou, Guoguang Lu, Shuaishuai Chen, Juping Du, Yufen Zheng, Shiyong Chen, Bo Shen, Jun Li et al. · 2022 · Frontiers in Pharmacology
92. The therapeutic potential of natural products for treating pancreatic cancer
    Xia He, Ning Wang, Yu Zhang, Xiaobo Huang, Yi Wang · 2022 · Frontiers in Pharmacology
93. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma
    Yi Han, Pascal Drobisch, Alexander Krüger, Doreen William, Konrad Grützmann, Lukas Böthig, Heike Polster, Lena Seifert, Adrian M. Seifert, Marius Distler et al. · 2023 · Journal of Hematology & Oncology
94. Toxic mechanisms of cadmium and exposure as a risk factor for oral and gastrointestinal carcinomas
    Ali Tavakoli Pirzaman, Pouyan Ebrahimi, Shokat Niknezhad, Turan vahidi, Dariush Hosseinzadeh, Sousan Akrami, Arash M. Ashrafi, Mohammad Moeen Velayatimehr, Rezvan Hosseinzadeh, Sohrab Kazemi · 2023 · Human & Experimental Toxicology
95. Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
    Ariadna Martín-Blázquez, Cristina Jiménez‐Luna, Caridad Díaz, Joaquina Martínez-Galán, Jose Carlos Prados, Francisca Vicente, Consolación Melguizo, Olga Genilloud, José Pérez del Palacio, Octavio Caba · 2020 · Cancers
96. Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
    Edward P. Carter, Abigail S. Coetzee, Elena Tomás Bort, Qiaoying Wang, Hemant Mahendrakumar Kocher, Richard Philip Grose · 2021 · Cells
97. Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression
    Se Jun Park, Kabsoo Shin, In-Ho Kim, Tae Ho Hong, MyungAh Lee, Younghoon Kim, Ja Hee Suh · 2023 · Journal of Clinical Medicine
98. Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients
    Debora Basile, Carla Corvaja, Riccardo Caccialanza, Giuseppe Aprile · 2019 · Current Opinion in Supportive and Palliative Care
99. YAP Inhibition by Nuciferine via AMPK-Mediated Downregulation of HMGCR Sensitizes Pancreatic Cancer Cells to Gemcitabine
    Ling Zhou, Qiaoyun Wang, Han Zhang, Youjie Li, Shuyang Xie, Maolei Xu · 2019 · Biomolecules
100. Targeting Mutant KRAS in Pancreatic Cancer: Futile or Promising?
     Friederike Inga Nollmann, Dietrich Alexander Ruess · 2020 · Biomedicines